Site Map
Instagram’s CEO knows you and Kylie Jenner are not happy the app is turning into TikTokWorld’s richest family loses $11.4 billion in Walmart routA housing recession is the first step to a Fed-induced recession. Here’s where the housing market goes nextThe next big threat to corporate diversity success is here‘This is not going to be a quick fix’: Heathrow chief says travel chaos could last through next yearJunior bankers beware, top analyst says: ‘If you’re an employee of Wall Street, you better have your eyes wide open’Wharton launches the first Ivy League crash course on the metaverse for business executivesAmazon Prime fees are going up in Europe, citing rising costsWant your company’s A.I. project to succeed? Don’t hand it to the data scientists, says this CEODemand destruction is here as sky-high gas prices have nearly two-thirds of Americans changing their lifestylesCOVID is at or near record levels around the country. Scientists say one (pretty gross) indicator doesn’t lieBig Tech is facing an unprecedented stress test—and the next 3 days will be keyThe IMF is officially ‘gloomy’ as it slashes its outlook with the global economy ‘teetering on the edge’ of a return to the stagflationary 1970s China has been waging a secret decade-long campaign targeting U.S. economic data, and the Fed’s defense is a joke, senator saysReddit co-founder Alexis Ohanian says he’s ‘very serious’ about his offer to save the Choco TacoFrontier and JetBlue are at a stalemate in months-long merger battle for SpiritBillionaire Binance CEO CZ sues Businessweek’s Hong Kong publisher over ‘Ponzi scheme’ languageBosses are oblivious to the real reason employees are quittingClimate change’s freakishly hot summer is leading to a new type of insurance coverage—for heat strokeTikTok ‘travel hack’ blamed by major airport chief for delaying disabled passengersFacebook considers relaxing COVID-19 misinformation policiesFast food founder buys $100,000 in lottery tickets, says he’ll share winnings with employeesHIV prevention drug PrEP is on trial as lawyer behind Texas abortion ban seeks to block coverage mandate under the ACARome’s Colosseum has just been given an actual price tag — and it’s bigYes, you’re allowed to cry at work now. Your coworkers think it’s weird if you don’t show emotionShopify is showing 1,000 staffers the door today as CEO admits he ‘bet’ on e-commerce—and he was wrongFormer CVS executive Helena Foulkes is running for Rhode Island governor on the strength of her business background: ‘It’s about getting stuff done’Coinbase under investigation after outburst against SECEurope’s travel chaos set to get even worse as Lufthansa ground-staff strike causes 1,000 flight cancellationsTwitter hacker touting the data of over 5.4 million users, including celebrities and companies, for $30,000Tech M&A’s surprising acceleration despite a sputtering economyBillionaire twin brothers brawled on a luxury yacht over the control of their U.K. business empire, a London court hearsEmployees are living—and working—longer. CEOs are introducing initiatives like phased retirements to harness the ‘longevity economy’Mystery of global uptick in hepatitis affecting children may have been solvedA COVID outbreak in Shenzhen has forced 100 manufacturers into a ‘closed-loop’ system, threatening a new wave of supply-chain chaosBeijing is trying to stop Pelosi from visiting the leading supplier of chips to the U.S., warning it is ‘seriously prepared’ to retaliate if she goes to TaiwanNew KPIs are ‘creating tensions in the C-suite,’ says an MIT researcherGen Z, rejoice: Most of the bosses who insist on return to office will retire soonLow-carb diets: an expert explains how they work and if they’re right for youHybrid work is looking like a silver bullet for cutting down on employee churnDistracted by the statistical debate over inflation? Here’s the real questionAmsterdam is tired of being Europe’s cheap flights hubIt’s time to expose the secret drug scam at the heart of American health careWalmart woes show Americans are cutting their clothing budget as food costs riseChina just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
CareersEntertainmentVenture CapitalCoronavirusAutosChinaMarketsThe Travel IndustryEnergyA.I.BitcoinFood and DrinkSportsLuxuryPoliticsEconomyCybersecurityReal EstateRussiaStartupsDiversity and InclusionElectionsInflationChief Executive Officer (CEO)InvestingEarningsSocial MediaTaxesClimate ChangeIPOsNetflixPharmaceutical IndustryFederal ReserveLaborMergers and AcquisitionsElectric VehiclesPrivate EquityCongressHousingUnemploymentRemote WorkBanksInterest RatesMental HealthLayoffsHuman ResourcesStudent Loans and DebtGen ZWealthNutrition